Skip to main content
Erschienen in: Journal of Inherited Metabolic Disease 6/2009

01.12.2009 | ORIGINAL ARTICLE

Ear symptoms in children with Fabry disease: data from the Fabry Outcome Survey

verfasst von: A. Keilmann, D. Hajioff, U. Ramaswami, on behalf of the FOS Investigators

Erschienen in: Journal of Inherited Metabolic Disease | Ausgabe 6/2009

Einloggen, um Zugang zu erhalten

Summary

Background: Hearing loss and tinnitus are common symptoms in Fabry disease and increase in prevalence with age. This study aimed to provide an epidemiological description of hearing impairment and tinnitus in children with Fabry disease in the Fabry Outcome Survey (FOS), an international database to assess the natural history of Fabry disease and the efficacy of enzyme replacement therapy with agalsidase alfa. Methods: Signs and symptoms questionnaires were completed for 543 children with Fabry disease. Pure-tone audiograms were obtained from 101 children (53 girls, 48 boys). Results: On questioning, 33% of the children (n = 179) reported subjective hearing impairment. However, when assessed by age-appropriate audiometry, only 19 of 101 patients (19%) had a persistent hearing loss at least one frequency. Of these, 14 had a high-frequency hearing loss, 4 a pan-frequency hearing loss, and 1 a pattern typical of noise-induced loss. Of the 101 children with audiometry, 44 complained of tinnitus. Only 2 children reported sudden hearing loss, which was not verified by audiometry. Children with tinnitus had greater disease severity scores. Conclusions: Hearing loss is a well-known clinical manifestation in patients with Fabry disease. It was reported in significant numbers of children in the FOS signs and symptoms questionnaire, but confirmed in only 19% by formal audiometry. The subjective hearing impairment may have been due to middle-ear effusions in many cases. Tinnitus is a well-recognized symptom in Fabry disease and can present in childhood. The presence of tinnitus correlated with overall disease severity.
Literatur
Zurück zum Zitat Baguley DM, McFerran DJ (1999) Tinnitus in childhood. Int J Pediatr Otorhinolaryngol 49:99–105CrossRefPubMed Baguley DM, McFerran DJ (1999) Tinnitus in childhood. Int J Pediatr Otorhinolaryngol 49:99–105CrossRefPubMed
Zurück zum Zitat Davidson J, Hyde ML, Alberti PW (1989) Epidemiologic patterns in childhood hearing loss: a review. Int J Pediatr Otorhinolaryngol 17:239–266CrossRefPubMed Davidson J, Hyde ML, Alberti PW (1989) Epidemiologic patterns in childhood hearing loss: a review. Int J Pediatr Otorhinolaryngol 17:239–266CrossRefPubMed
Zurück zum Zitat Fiellau-Nikolajsen M (1980) Tympanometry and middle ear effusion: a cohort-study in three-year-old children. Int J Pediatr Otorhinolaryngol 2:39–49CrossRefPubMed Fiellau-Nikolajsen M (1980) Tympanometry and middle ear effusion: a cohort-study in three-year-old children. Int J Pediatr Otorhinolaryngol 2:39–49CrossRefPubMed
Zurück zum Zitat Germain DP, Avan P, Chassaing A, Bonfils P (2002) Patients affected with Fabry disease have an increased incidence of progressive hearing loss and sudden deafness: an investigation of twenty-two hemizygous male patients. BMC Med Genet 3:10CrossRefPubMedPubMedCentral Germain DP, Avan P, Chassaing A, Bonfils P (2002) Patients affected with Fabry disease have an increased incidence of progressive hearing loss and sudden deafness: an investigation of twenty-two hemizygous male patients. BMC Med Genet 3:10CrossRefPubMedPubMedCentral
Zurück zum Zitat Hajioff D, Hegemann S, Conti G et al. (2006) Agalsidase alpha and hearing in Fabry disease: data from the Fabry Outcome Survey. Eur J Clin Invest 36:663–667CrossRefPubMed Hajioff D, Hegemann S, Conti G et al. (2006) Agalsidase alpha and hearing in Fabry disease: data from the Fabry Outcome Survey. Eur J Clin Invest 36:663–667CrossRefPubMed
Zurück zum Zitat Hegemann S, Hajioff D, Conti G et al. (2006) Hearing loss in Fabry disease: data from the Fabry Outcome Survey. Eur J Clin Invest 36:654–662CrossRefPubMed Hegemann S, Hajioff D, Conti G et al. (2006) Hearing loss in Fabry disease: data from the Fabry Outcome Survey. Eur J Clin Invest 36:654–662CrossRefPubMed
Zurück zum Zitat Holgers KM (2003) Tinnitus in 7-year-old children. Eur J Pediatr 162:276–278PubMed Holgers KM (2003) Tinnitus in 7-year-old children. Eur J Pediatr 162:276–278PubMed
Zurück zum Zitat Holgers KM, Juul J (2006) The suffering of tinnitus in childhood and adolescence. Int J Audiol 45:267–272CrossRefPubMed Holgers KM, Juul J (2006) The suffering of tinnitus in childhood and adolescence. Int J Audiol 45:267–272CrossRefPubMed
Zurück zum Zitat Hughes GB, Freedman MA, Haberkamp TJ, Guay ME (1996) Sudden sensorineural hearing loss. Otolaryngol Clin North Am 29:393–405PubMed Hughes GB, Freedman MA, Haberkamp TJ, Guay ME (1996) Sudden sensorineural hearing loss. Otolaryngol Clin North Am 29:393–405PubMed
Zurück zum Zitat ISO (1989) Acoustics – Audiometric test methods – Part 1: Basic pure tone air and bone conduction threshold audiometry. ISO 8253–1. Available online at: http://www.iso.org Accessed 21 Feb 2009 ISO (1989) Acoustics – Audiometric test methods – Part 1: Basic pure tone air and bone conduction threshold audiometry. ISO 8253–1. Available online at: http://​www.​iso.​org Accessed 21 Feb 2009
Zurück zum Zitat Keilmann A (2003) Inner ear function in children with Fabry disease. Acta Paediatr Suppl 92:31–32; discussion 27CrossRefPubMed Keilmann A (2003) Inner ear function in children with Fabry disease. Acta Paediatr Suppl 92:31–32; discussion 27CrossRefPubMed
Zurück zum Zitat Lee CA, Mistry D, Uppal S, Coatesworth AP (2005) Otologic side effects of drugs. J Laryngol Otol 119:267–271PubMed Lee CA, Mistry D, Uppal S, Coatesworth AP (2005) Otologic side effects of drugs. J Laryngol Otol 119:267–271PubMed
Zurück zum Zitat Limberger A, Beck M, Delgado-Sanchez S, Keilmann A (2007) [Hearing loss in patients with Fabry disease]. HNO 55:185–189CrossRefPubMed Limberger A, Beck M, Delgado-Sanchez S, Keilmann A (2007) [Hearing loss in patients with Fabry disease]. HNO 55:185–189CrossRefPubMed
Zurück zum Zitat Mehta A, Ricci R, Widmer U et al. (2004) Fabry disease defined: baseline clinical manifestations of 366 patients in the Fabry Outcome Survey. Eur J Clin Invest 34:236–242CrossRefPubMed Mehta A, Ricci R, Widmer U et al. (2004) Fabry disease defined: baseline clinical manifestations of 366 patients in the Fabry Outcome Survey. Eur J Clin Invest 34:236–242CrossRefPubMed
Zurück zum Zitat Ramaswami U, Whybra C, Parini R et al. (2006) Clinical manifestations of Fabry disease in children: data from the Fabry Outcome Survey. Acta Paediatr 95:86–92CrossRefPubMed Ramaswami U, Whybra C, Parini R et al. (2006) Clinical manifestations of Fabry disease in children: data from the Fabry Outcome Survey. Acta Paediatr 95:86–92CrossRefPubMed
Zurück zum Zitat Ries M, Ramaswami U, Parini R et al. (2003) The early clinical phenotype of Fabry disease: a study on 35 European children and adolescents. Eur J Pediatr 162:767–772CrossRefPubMed Ries M, Ramaswami U, Parini R et al. (2003) The early clinical phenotype of Fabry disease: a study on 35 European children and adolescents. Eur J Pediatr 162:767–772CrossRefPubMed
Zurück zum Zitat Ries M, Kim HJ, Zalewski CK et al. (2007) Neuropathic and cerebrovascular correlates of hearing loss in Fabry disease. Brain 130:143–150CrossRefPubMed Ries M, Kim HJ, Zalewski CK et al. (2007) Neuropathic and cerebrovascular correlates of hearing loss in Fabry disease. Brain 130:143–150CrossRefPubMed
Zurück zum Zitat Seifert E, Brosch S, Dinnesen AG et al. (2005) [Peripheral hearing disorders in childhood. Results of an evidenced based consensus conference]. HNO 53:376–382PubMed Seifert E, Brosch S, Dinnesen AG et al. (2005) [Peripheral hearing disorders in childhood. Results of an evidenced based consensus conference]. HNO 53:376–382PubMed
Zurück zum Zitat WHO (1980) International classification of impairments, disabilities and handicaps: a manual of classification related to the consequences of disease. WHO, Geneva WHO (1980) International classification of impairments, disabilities and handicaps: a manual of classification related to the consequences of disease. WHO, Geneva
Zurück zum Zitat Whybra C, Kampmann C, Krummenauer F et al. (2004) The Mainz Severity Score Index: a new instrument for quantifying the Anderson–Fabry disease phenotype, and the response of patients to enzyme replacement therapy. Clin Genet 65:299–307CrossRefPubMed Whybra C, Kampmann C, Krummenauer F et al. (2004) The Mainz Severity Score Index: a new instrument for quantifying the Anderson–Fabry disease phenotype, and the response of patients to enzyme replacement therapy. Clin Genet 65:299–307CrossRefPubMed
Zurück zum Zitat Whybra C, Baehner F, Baron K (2006) Measurement of disease severity and progression in Fabry disease. In: Mehta A, Beck M, Sunder-Plassmann G (eds) Fabry disease: perspectives from 5 years of FOS. Oxford PharmaGenesis Ltd, Oxford, 315–322 Whybra C, Baehner F, Baron K (2006) Measurement of disease severity and progression in Fabry disease. In: Mehta A, Beck M, Sunder-Plassmann G (eds) Fabry disease: perspectives from 5 years of FOS. Oxford PharmaGenesis Ltd, Oxford, 315–322
Metadaten
Titel
Ear symptoms in children with Fabry disease: data from the Fabry Outcome Survey
verfasst von
A. Keilmann
D. Hajioff
U. Ramaswami
on behalf of the FOS Investigators
Publikationsdatum
01.12.2009
Verlag
Springer Netherlands
Erschienen in
Journal of Inherited Metabolic Disease / Ausgabe 6/2009
Print ISSN: 0141-8955
Elektronische ISSN: 1573-2665
DOI
https://doi.org/10.1007/s10545-009-1290-x

Weitere Artikel der Ausgabe 6/2009

Journal of Inherited Metabolic Disease 6/2009 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.